Latest Cost Savings News

CLINUVEL Pharmaceuticals is relocating its corporate headquarters to the United States and reducing its global workforce by up to 20%, realigning its operations to focus solely on the US pharmaceutical market and unlock greater capital access.

Eden Innovations has secured robust validation from India’s Central Road Research Institute showing its EdenCrete®Pz7 carbon nanotube admixture boosts concrete strength, durability, and sustainability in key infrastructure mixes.

Praemium’s total Funds Under Administration surged 21% to $77.9 billion in FY26, driven by strong platform net inflows and robust growth in non-custodial portfolio administration.

IDT Australia boosts its FY26 revenue guidance to $16.8 million, anticipating a substantial narrowing of EBITDA losses to under $1 million, driven by strong demand and cost efficiencies.

International Equities Corporation Ltd (ASX:IEQ) posted a modest profit for the June 2026 quarter, reversing prior losses amid a challenging economic backdrop that forced the company to exit its hotel and tourism activities.

Iltani Resources has demonstrated significant grade upgrades and waste rejection in first-pass TOMRA ore sorting tests at its Orient Silver-Indium Project, advancing plans for bulk testing and potential cost savings.

Coventry Group’s Q4 FY26 results show a strong operational turnaround with sales up 11.7% quarter-on-quarter and EBITDA almost doubling to $4.1 million, backed by a $10 million cost reduction program and positive cash flow.

Microba Life Sciences has delivered robust FY26 growth in its core microbiome testing business, with revenues up 92% year-on-year and a new GI Navigator product set for launch in September 2026. The company also announced a $7 million annualised cost reduction program as it advances towards cashflow break-even.

EQT’s controlled entity has upped its non-binding offer for Perpetual to A$22.07 per share, a 2% premium on its initial bid. The proposal hinges on Perpetual’s Wealth Management sale and other conditions, with no certainty of a deal.

Alfabs Australia has strengthened its financial footing in Q4 FY26, commissioning new mining equipment and cutting costs to reduce net debt and progress towards dividend reinstatement.

Synertec has expanded its Powerhouse footprint with Santos, adding two new solar-plus-storage systems to power coal seam gas wells under a high-margin BOOM model.

HeraMED's Phase 1 pilot with Lee Health confirms strong patient adoption and operational efficiency for its digital maternity care platform, setting the stage for broader US rollout.